National Institute of Neurological Disorders and Stroke (NINDS)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Neurological Disorders and Stroke (NINDS) sits in the top decile of US sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count).
National Institute of Neurological Disorders and Stroke (NINDS): 567 sponsored US clinical trials, 48 recruiting.
National Institute of Neurological Disorders and Stroke (NINDS) sponsors 567 registered US clinical trials on ClinicalTrials.gov, 48 of them currently recruiting, and 467 completed. 16 of these trials are in Phase 3-4 (later-stage) and 158 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 23 trials.
Top-decile sponsor footprint
National Institute of Neurological Disorders and Stroke (NINDS) ranks in the top decile of sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
467 of 508 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
567 total, page 5 of 12
Detecting a Reward Signal in the Motor Cortex
NCT00422071
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621
Effects of tDCS Over the Cerebellum on Motor Function
NCT00413842
Enhancing Brain Activity With Magnetic Stimulation
NCT00396890
Motor Skill Learning in People With Parkinson's Disease
NCT00396942
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00393588
Enhancing Motor Task Training by Action Observation Watching Others Perform the Task
NCT00393432
Brain Connectivity Between Visual Input and Movement
NCT00376545
Muscle Contraction in Patients With Focal Hand Dystonia
NCT00376753
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
NCT00391378
Hypersensitivity in Tourette Syndrome
NCT00368433
Influence of Theta Burst Stimulation and Carbidopa-Levodopa on Motor Performance in Stroke Patients
NCT00366184
Collection of Blood Samples for DNA in Motor Neuron Disease
NCT00362362
Plasma Exchange for Autoimmune Autonomic Failure
NCT00359346
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia
NCT00376506
Brain Stimulation to Treat Blepharospasm or Meige Syndrome
NCT00411255
Electrical Brain Stimulation to Reduce Epileptic Seizures
NCT00344877
Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis
NCT00334516
Gait Training and Brain Changes in Stroke Patients
NCT00334230
Improving Hand Movement Training Through Electrical Stimulation of the Brain
NCT00331318
Long-Term Motor Learning in Focal Hand Dystonia
NCT00325091
Plasticity in Cervical Dystonia
NCT00323765
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00321568
Long-Term Improvement in Motor Learning by Transcranial Direct Current Stimulation
NCT00314769
Treatment for Psychogenic Disorders
NCT00314444
fMRI Studies of Task Specificity in Focal Hand Dystonia
NCT00310414
Neurophysiology of Task-Specificity of Focal Hand Dystonia
NCT00309010
Physiology of Weakness in Movement Disorders
NCT00307346
Transcranial Direct Current Stimulation to Improve Hand Movement in Stroke Patients
NCT00307385
Volitional Swallowing in Stroke Patients With Chronic Dysphagia
NCT00306501
Brain Changes in Patients With Focal Hand Dystonia
NCT00306865
Reference Values for Plasma Catechols
NCT00267904
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
NCT00303446
Interaction of Right and Left Brain Hemispheres in Learning Precision Hand Movements
NCT00295568
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
NCT00293748
Measures of Motor Impairment in Early Parkinson's Disease
NCT00291265
Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
NCT00285324
Brain Networks Responsible for Sense of Agency
NCT00283907
Tactile Learning in Stroke Patients
NCT00283881
Electrical Polarization of the Brain in Corticobasal Syndrome
NCT00273897
Brain Changes in Adolescents While Imagining and Observing Aggressive Behavior
NCT00267891
Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure
NCT00255411
Training for Diagnosing Neurological Disorders
NCT00132353
Brain Networks Responsible for Self-Agency
NCT00246831
PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency
NCT00246870
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
NCT00244582
Moving a Paralyzed Hand Through Use of a Brain-Computer Interface
NCT00242242
Idebenone to Treat Friedreich's Ataxia
NCT00229632
Brain Activity Associated With Tics in Patients With Tourette Syndrome
NCT00141869
Movement-Related Brain Networks Involved in Hand Dystonia
NCT00137384
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 78 |
| Phase 3 | 11 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the National Institute of Neurological Disorders and Stroke (NINDS) pipeline
48 recruiting of 567 indexed (8% open); 467 completed (82%).
Phase mix: 16 late (III/IV) vs 158 early (I/II) (early-phase heavy).
Top condition: Healthy (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Neurological Disorders and Stroke (NINDS): open-pipeline peers nationwide
Peers matched on 567 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
National Institute of Neurological Disorders and Stroke (NINDS) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 567 trials (± recruiting share)
- Children's Hospital Medical Center, Cincinnati · 571 trials · 19% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Jewish Health · 8% recruiting · 83 trials
- ACADIA Pharmaceuticals · 9% recruiting · 35 trials
- Texas Tech University Health Sciences Center, El Paso · 9% recruiting · 35 trials
- Boehringer Ingelheim · 8% recruiting · 515 trials
Related
What to do with this National Institute of Neurological Disorders and Stroke (NINDS) page
567 registered trials is a research-attention snapshot, not an endorsement of National Institute of Neurological Disorders and Stroke (NINDS) or any single study.
- 48 of National Institute of Neurological Disorders and Stroke (NINDS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Neurological Disorders and Stroke (NINDS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institute of Neurological Disorders and Stroke (NINDS) pipeline card: 567 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.